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EXAMINATION OF SOMATIC SYMPTOMATOLOGY USING THE CLEVELAND 
ADAPTIVE PERSONALITY INVENTORY AND THE DIMENSIONAL SOMATIC 
QUESTIONNAIRE 
ELIZABETH KISELA 
ABSTRACT 
This study was designed to assess the reliability and validity of the Cleveland Adaptive 
Personality Inventory (CAPI) and the Dimensional Somatic Questionnaire (DSQ) on the 
chronic pain population, depression population, and healthy control population. A total of 
178 chronic pain participants, 208 depression participants, and 220 healthy control 
participants were collected, though not all were used for analysis due to missing data. 
Each participant was administered an online version of the CAPI with the Dimensional 
Somatic Questionnaire. Both questionnaires were significantly shortened during or prior 
to analysis. The questionnaires were shortened to make them more practical for use in the 
clinical setting. This study documented acceptable to excellent reliability for all 10 main 
scales of the CAPI across all three groups. Additional findings for the CAPI showed that 
the somatic scale and depression scale were highly sensitive and specific to the chronic 
pain and depression populations, respectively. The DSQ demonstrated excellent overall 
reliability. The DSQ was not found to be useful in distinguishing between chronic 
somatic symptomatology and chronic emotional symptomatology and was not found to 
have three constructs (e.g. mental health, emotional health, and behavioral health). 
However, it was found sensitive and specific to chronic pain patients and would be useful 
in deciphering the amount of functional impairment a chronic pain participant may have. 
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CHAPTER I 
INTRODUCTION 
 
1.1 Background 
 
A report written in 2011 by the Institute of Medicine, in collaboration with the 
National Academy of Sciences, stated that the United States spends up to $635 billion 
each year in medical treatment and lost productivity due to chronic pain. The quality of 
life for people who suffer from chronic pain is greatly diminished and because of this, 
chronic pain patients can develop psychological issues like depression or anxiety. 
Chronic pain occurs in 33% of adult Americans (Johannes, Kim Le, Zhou, Johnston, & 
Dworkin, 2010). To more efficiently diagnose and productively treat the 33% of 
American adults as well as many other chronic pain patients around the world, a 
personality assessment and somatic questionnaire are necessary to streamline the process. 
 
 
   
 
2 
 
1.1.1 Somatic Manifestations and the Medical Community 
 
 It has been a long road for the outside world to believe that emotional problems 
can manifest themselves into physical illnesses. Freud developed theories regarding 
traumatic hysteria in the late 1800s, but due to the inability to replicate his work 
scientifically, his work was falling on deaf ears in the medical community (Aron & Starr, 
2013). What did emerge from Freud’s work was the recognition that irritability, mood 
changes, and pain are often symptoms of a psychosomatic problem, not simply a medical 
one. Even in the more recent medical community, studies have shown that anywhere 
from 25% to 50% of patients seen by physicians have psychological disorders in addition 
to medical problems (Asaad, 2000; Mostofsky & Barlow, 2000); and many of those 
patients are left undiagnosed and not referred for treatment of those psychosocial 
probelms (American Journal of Managed Care, 1999).  
Freud eventually abandoned some of his theories regarding the cause of hysteria 
and the American Psychological Association (APA) dropped hysteria from The 
Diagnostic and Statistical Manual of Mental Disorders III (3rd ed.; DSM-III; American 
Psychiatric Association, 1952) officially, stating that hysteria is too morally laden to be 
considered a psychical condition (Libbrecht & Quackelbeen, 1995). The American 
Medical Association also no longer use the term hysteria as a medical diagnosis, although 
somatic manifestations were occurring without known etiology remains a common 
phenomenon. Given these findings, Grobin (1960) stated that the medical community has 
a difficult time accepting psychosomatic medicine as a true science and believing in the 
fact that a person’s psyche is directly related to the development and treatment of their 
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physical illness. He went on to begrudgingly admit that psychosomatic medicine offers a 
more comprehensive approach to the patient and the illness, but noted that questions 
remain as to whether the medical community at that time should take psychosomatic 
symptoms seriously.  
More recently there have been numerous studies done that show a patient’s 
mindset can influence the outcome of a surgical procedure and sometimes the cost and 
overall perception of success of the surgical procedure (Ayers, Franklin, & Ring, 2013; 
Fox et al., 2013; Sharma et al., 2016). More recent studies show that chronic pain, 
somatization, and psychosomatic issues may be a result of central sensitization, a central 
nervous system process causing hyperalgesia diffusely throughout the body (Woolf, 
2011; Meeus & Nijs, 2007; Phillips & Clauw, 2011). Following the understanding that 
mind and body symptoms are related, the medical community has become more 
accepting of psychosomatic medicine. This is evidenced by the numerous 
interdisciplinary pain rehabilitation programs available to patients who face somatic 
disorders, which include the Cleveland Clinic Foundation and the Mayo Clinic. Further 
evidence of the medical community’s acceptance are the relatively new requirements at 
many facilities of psychological evaluations prior to major surgeries.  
 
1.1.2 Gender and Chronic Pain 
 
It is a widely held clinical opinion that females are more susceptible to pain and 
exhibit more pain behaviors than their male counterparts (Lawlis, Achterberg, Kenner, & 
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Kopetz, 1984). Some pain modulation mechanisms and sex hormones could be 
contributing factors to this opinion (Nahman-Averbuch, Sprecher, Brill, Yarnitsky, & 
Jacob, 2016). There is even some research that suggests, in certain pain scenarios, the X 
chromosome has a role in how much pain is expressed, which makes women more likely 
to develop chronic, lasting pain (Linnstaedt, et al., 2015). No certain number of women 
or men were put into this trial despite the evidence that women may be more prone to 
exhibit pain and pain behaviors. A factor analysis of women and men separately was 
intended to be done to determine if factor structure is similar for both men and women, 
however, there was not enough men collected to perform a reliable analysis. 
 
1.1.3 Psychosocial Issues Derived from Chronic Illnesses 
 
Serious somatic symptoms, including chronic pain and fibromyalgia, cause a great 
deal of anger, depression, fatigue, and anxiety in people who have experienced them 
(Shuchang et al., 2011). Therefore, a great deal of research has been conducted to help 
people who experience these negative feelings chronically. New methods for identifying 
patients who are likely to develop chronic pain is therefore of great interest to both 
researchers and clinicians. Mansour et al. (2013), for example, studied, using brain 
imaging techniques, the white matter structural properties of pain patient and was able to 
predict the amount of pain manifested by at least eighty percent of the outcomes.  
Recent brain imaging studies show that there are new treatments for patients with 
chronic pain. For example, Deogaonkar et al. (2016) used functional magnetic resonance 
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imaging (fMRI) to map areas of the brain that modulate pain. In that study, it was 
demonstrated that the brain’s emotional networks, which process and facilitate emotional 
connectivity, could be relieved for chronic pain patients through therapeutic spinal cord 
stimulation. Although the study included only 10 patients, the results are informative and 
another stride forward in the treatment for patients who suffer from chronic pain.  
Studies like those that had been previously reviewed suggest that there is a 
growing need for reliable and valid measures for the diagnoses of chronic pain patients. 
A way to distinguish origin of chronic conditions can help current chronic pain patients 
find their way to relief through cutting edge medical treatments as they progress coupled 
with the best psychotherapy for their current psychosomatic stressors. Another reason 
why new measures are necessary would be because of the high comorbidity rates of 
depression and anxiety with chronic pain. Depression is the most frequent comorbid 
mood disorder with chronic pain, with anxiety as a close second (Von Korff et al., 2005).  
 
1.2 DSM-5, ICD-10, and CAPI with Dimensional Somatic Questionnaire 
 
The Diagnostic and Statistical Manual of Mental Disorders (5th ed.; DSM-5; 
American Psychiatric Association, 2013), is the current diagnostic manual for mental 
health professionals. It is a manual for the classification and diagnosis of mental disorders 
and is updated periodically by the American Psychiatric Association (APA). The 
International Statistical Classification of Diseases and Related Health Problems (10th 
revision; ICD-10; World Health Organization, 1992) is a coding system that most 
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healthcare providers in the United States use to classify a patient’s diagnoses, symptoms, 
procedures, and surgeries for use in billing and record-keeping for hospital care. It is a 
periodically updated with new illness types, symptoms, and procedures by the World 
Health Organization (WHO) and implemented throughout the United States’ medical 
facilities. Every diagnosis in the DSM-5 is directly linked to an ICD-10 code.  
 
1.3 Why is a New Somatic Scale Needed? 
 
A reliable, valid personality assessment that is directly linked to DSM-5 criteria 
for psychosomatic disorders and ICD-10 diagnosis codes for somatization disorders 
would make diagnosing and treating somatically stricken patients with mental health 
issues more efficient and more effective.  
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CHAPTER II 
REVIEW OF EXISTING MEASURES 
 
2.1 Physical Health Questionnaire-15 
 
A popular and often-used scale in the health care setting for somatization is the 
Physical Health Questionnaire-15 (PHQ-15) (Kroenke, Spitzer, & Williams, 2002) which 
recently produced the abbreviated version called the Somatic Symptom Scale-8 (SSS-8) 
(Gierk et al., 2013). The PHQ-15 is an assessment used to identify symptoms over the 
last four weeks while the SSS-8 is used to identify symptoms over the past seven days. 
Both measures have been empirically tested for validity and reliability and fare quite well 
(Gierk et al., 2015).  
 The PHQ was developed as a small part of a Type A behavior pattern assessment 
by Spence, Helmreich, and Pred (1987). Looking at physical health was not a focus for 
their study; instead, the PHQ was developed to look at four dimensions of somatic health: 
quality of sleep, digestion issues, headaches, and respiratory problems. When initially 
created and studied, Spence et al. (1987) reported that all four subscales were 
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significantly intercorrelated (ranging from .17 to .43) and their internal consistency 
reliabilities were above α = .75. The more recent overall index including only 14 items 
was developed and used by Rogers and Kelloway (1997) and Schat and Kelloway (2000, 
2003) in workplace aggression and violence studies. The original PHQ included 32 items, 
while the revised and more recently utilized PHQ was minimized to a 14-item scale using 
only three dimensions, excluding the respiratory problems dimension. Once that scale 
was developed, an overall index of somatic health based questionnaire was created on all 
items. Both scales, subscale and overall index, showed reliabilities above α = .80 in 
separate studies (Rogers & Kelloway, 1997; Schat & Kelloway, 2000; Schat & Kelloway, 
2003). In a study done by Schat, Kelloway, and Desmarais (2005), despite having 
narrowed down the dimensions to three and being reliable in measuring an overall 
somatic symptomatology index, the PHQ was found to be a psychometrically sound 
instrument that measures four dimensions: gastrointestinal problems, headaches, sleep 
disturbances, and respiratory illness. This outcome is very similar to the original, but it 
has only half of the questions, making it very usable for current clinicians.  
 
2.2 Somatic Symptom Scale-8 
 
The SSS-8 is an even shorter version of the PHQ-15. It has good internal 
consistency (α = .81) and it also measures four dimensions: gastrointestinal issues, pain, 
fatigue, and cardiopulmonary somatic aspects. The SSS-8 was significantly associated 
with depression, anxiety, health status, and use of the health care system by a self-report 
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survey in Germany using a random-route sampling procedure and doing analysis on 
2,510 participants’ responses (Gierk et al., 2013). When studied by Gierk et al. (2014), 
the abbreviated version of PHQ-15, was found to identify individuals with low, medium, 
high, and very high somatic symptom burden. The SSS-8 was also found to have a higher 
correlation between somatic symptom burden to depression and anxiety than to general 
health status. This finding could suggest that somatic symptoms and mental health have a 
comorbid relationship. While the SSS-8 shows that this relationship exists, the CAPI and 
Dimensional Somatic Questionnaire can expand on that relationship to see if it is strong 
enough for diagnosis.  
 The PHQ-15 and the SSS-8 do measure symptoms but they do not measure a 
patient’s personality and combine those results in making a tentative diagnosis as the 
somatic scales on the CAPI will hopefully accomplish. The PHQ-15 and SSS-8 are 
primary used in order to determine symptomatology for a physical ailment and make no 
attempt in correlating their results to any mental health criteria. The Dimensional Somatic 
Questionnaire in congruence with the CAPI will allow for mental health professionals 
and physicians to get a better understanding of how these somatic symptoms are affecting 
their patients’ thought processes in a mental health capacity.  
 
2.3 Minnesota Multiphasic Personality Inventory (MMPI) 
 
The MMPI is one of the most widely used personality assessment commercially 
available (Butcher & Perry, 2008; Kleinmuntz, 1967; Lanyon & Goodstein, 1982), which 
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is why there has been an ample amount of research conducted on the MMPI (Butcher & 
Perry, 2008; Lanyon & Goodstein, 1982). It is used in a variety of settings, including: the 
military, employment settings, police officers, and clinical inpatient and outpatient 
settings.  
 
2.3.1 MMPI Hypochondriasis Scale 
 
The Hypochondriasis scale of the MMPI and subsequent editions of the MMPI is 
a scale that was developed to identify patients displaying a pattern of symptoms 
associated with health and illness anxiety (Graham, 1990). A number of different 
constructs labeled poor physical health, digestive difficulties, bad eyesight, lung damage, 
poor bowel function, hypochondriasis, sinusitis, and hospitalization deal specifically with 
somatic concerns and can be conceptualized into a simple, unidimensional scale: 
hypochondriasis.  
When a person scores extremely high (T>80) on this scale on the MMPI, bizarre 
and exaggerated somatic complaints are likely occurring. This scale can be coupled with 
other scales, which have yet to be developed in the CAPI, to develop more complex 
diagnoses for an individual. Scores in the high mid-range (T=60-80) typically identify 
patients with stomach issues. Patients who have true physical problems generally do not 
exceed T≤60. If a patient with a true physical problem scores higher than a 60, a 
psychological issue should be strongly considered.  
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As the MMPI is a personality assessment, personality traits can be discerned for 
patients who score at certain levels on this test. High scorers on the hypochondriasis scale 
(T>60) are likely narcissistic and self-involved with a negative, pessimistic outlook on 
life. This type of person generally feel miserable and dissatisfied and makes life for their 
caregivers, family, and friends difficult by being demanding, critical, and indirectly 
hostile toward them. With these high scorers, their pain is more likely to be longstanding 
and the person may have minimal healthy coping mechanisms for their pain. Moderately 
high and high scorers tend to lack insight to the actual psychological causes or aspects of 
their physical presentation and have a hard time accepting psychological interpretation, 
this makes treatment methods more difficult. Because this scale is unidimensional, low 
scorers are typically the opposite of high scorers and are more accepting of treatment 
(Graham, 1990).  
 The MMPI-2 was used in a chronic pain research project and expanded on the 
MMPI hypochondriasis scale. Some questions were deleted and some modified for a 
multitude of reasons for the MMPI-2, so re-standardizing and confirming validity and 
reliability in the chronic pain subgroup was necessary. The analysis used a sample of 
chronic pain patients in the Minnesota and Midwestern region. The control group, 
however, was not a group in the Midwestern region and was not a medical population, 
which would have been the ideal control population for re-standardization of the MMPI-2 
(Keller & Butcher, 1991). The population that the CAPI will be using as a control will be 
in the medical community, but will not be suffering from chronic pain symptoms. The 
CAPI with the Dimensional Somatic Questionnaire will likely offer similar outcomes to 
the MMPI with fewer questions, ease of taking it online for free, and will continually be 
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developed further by the top minds in the chronic pain world to make for the best 
coverage of all the possible symptoms involved. Creating the CAPI and the Dimensional 
Somatic Questionnaire is an endeavor to create more reliable and valid data than the 
MMPI Hypochondriasis scale provides, which will allow for an implementation of a 
treatment regimen and diagnosis that can be counted on by the treating physician and/or 
psychologist. 
 
2.4 The Cleveland Adaptive Personality Inventory (CAPI) 
 
The CAPI (Poreh, 2007) was in development for over a decade. The purpose of 
this new measure is to apply adaptive methodology, much like the one proposed by 
Butcher (2000) toward the study of personality functioning. While the Minnesota 
Multiphasic Personality Inventory (MMPI), the Millon Clinical Multiaxial Inventory 
(MCMI), and the Personality Assessment Inventory (PAI) are expensive, and too lengthy 
for use in many medical settings, the CAPI is shorter, after the most recent revision, free 
upon request, and geared toward the ICD-10. The expense of existing multidimensional 
measures is a barrier because several somatoform disorders have their highest incidence 
in the lower socioeconomic status patient population (American Psychiatric Association, 
2013), and these patients are unlikely to be able to afford the expense of the test.  
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2.5 Development of the Dimensional Somatic Questionnaire 
 
There are many somatization scales being utilized by medical professionals today 
(Zijlema et al., 2013). The scales used today and the somatization scales used in the past 
ask a variety of questions that can be clustered into a number of constructs such as 
gastrointestinal issues, fatigue, cardiopulmonary issues, bodily preoccupation, 
hypochondriasis, disease phobia, and concerns about pain. These constructs were used to 
develop a symptom profile with little incorporation of mental health diagnosis. The CAPI 
and Dimensional Somatic Questionnaire aims to get an understanding of the 3 broader 
constructs: mental health, behavioral health, and emotional health of the patient 
presenting with somatic complaints. By using the three broad constructs (mental, 
behavioral, and emotional health) and a lie scale, the patient will be able to convey their 
specific mental disorder, if one is present. The focus of the Dimensional Somatic 
Questionnaire is to not only develop the symptom profile of the patient, much like the 
numerous other somatic scales in use today, but to also give insight to how severe the 
patient’s mental health problems may be. This will give the practitioner a clearer view of 
how to diagnose and treat the individual during and after their assessment. 
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CHAPTER III 
METHOD 
 
3.1 Participants 
 
The chronic pain participants included in this research experiment were subjects 
enrolled in ResearchMatch.org who had self-reported a diagnosis of chronic pain, 
fibromyalgia, or any other serious somatic symptom disorder. The control sample of this 
research experiment included subjects enrolled in ResearchMatch.org who had not self-
reported a diagnosis of chronic pain, fibromyalgia, or any other serious somatic symptom 
disorder causing pain. The depression sample of this research experiment included 
subjects enrolled in ResearchMatch.org who had self-reported a current or past diagnosis 
of any kind of depression.  
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3.2 Procedure  
 
In the initial stage of development of the somatic scales for the CAPI items were 
generated per the DSM-5 and ICD-10 criteria of each somatic disorder in the somatic 
symptoms and related disorders chapter. All the items are measured on a 4-point Likert 
scale (true, mostly true, mostly false, and false). Items have been adopted and modified 
from previously published measures. The final item pool includes 330 questions for the 
CAPI and an additional 56 questions for the Dimensional Somatic Questionnaire. 
 Participants contacted through ResearchMatch.org were contacted only if they 
had self-disclosed a diagnosis of fibromyalgia or chronic pain. The control participants 
contacted through ResearchMatch.org were contacted if they had not disclosed any 
psychological disorder, chronic pain, or fibromyalgia diagnoses. Another group of 
participants, who have disclosed a diagnosis of depression, were included to establish if 
somatic pain disorders can be distinguished from emotional pain disorders, like 
depression. 
 Once participants were deemed eligible, they were invited through 
Researchmatch.org to participate in the CAPI and the Dimensional Somatic 
Questionnaire. If accepted, they consented and demographic questions were asked, 
including: age, gender, level of education, list of all current medical conditions, list of all 
medications the participant is currently taking, and to identify how the developed chronic 
pain (if they had chronic pain). All participants were administered the CAPI with the 
   
 
16 
 
Dimensional Somatic Questionnaire. It is estimated that it took 60-120 minutes to 
complete both the CAPI and the DSQ. 
 A total of 178 participants were collected for the chronic pain group, 208 
participants were collected for the depression group, and 220 healthy control participants 
were collected. After removing all participants who had more than 10 missing answers, a 
total of 134 were in the chronic pain group, 137 in the depression group, and 151 in the 
healthy control group for the CAPI questionnaire. An additional 1 participant was 
removed in the depression group and 2 participants were removed in the healthy control 
group for the DSQ analysis due to 5 or more missing answers on the DSQ. The chronic 
pain group did not have any participants removed for the DSQ analysis. The DSQ had a 
repeat question, numbers 18 and 55, so question 55 was removed prior to analysis.  
 Reliability was measured using Cronbach α for the CAPI and DSQ. Validity was 
measured by ROC curve for both questionnaires. A factor analysis for the DSQ and a 
one-way ANOVA for the CAPI were used to measure validity as well. Mean T-score 
profiles for the CAPI were established for healthy participants, chronic pain participants, 
and depressed participants.    
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CHAPTER IV 
RESULTS AND DISCUSSION 
 
4.1 CAPI Reliability and Validity 
 
 The full-version CAPI was given to each participant (330 questions), but during 
the process of this research, the CAPI was shortened to 173 questions. The questions 
were removed to make the personality inventory more practical in the clinical setting.  
All questions have remained the same during the process of shortening the CAPI, so the 
reliability and validity of only the newer, shorter version of the CAPI will be discussed. 
The CAPI has an excellent overall reliability (Cronbach α = .90). Tables I-IV 
show the reliability of the various scale across the three groups (chronic pain, depression, 
and healthy controls) as well as the overall reliability of the various scales for all groups 
combined. One sees that the reliability ranges from α = .69-.91 in the chronic pain group, 
α = .68-.92 in the depressed group, α = .72-.92 in the healthy control group, and α = .71-
.94 across all groups. 
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A one-way analysis of variance (ANOVA) for each scale was calculated on each 
of the three groups (chronic pain, healthy controls, and depressed participants) to 
determine if they significantly differ on all main scales of the CAPI. The analysis was 
significant at p<.01 or less, to correct for Type I error, for all scales: SOM: F(2, 427) = 
149.72, p<.001; DEP: F(2, 427) = 86.36, p<.001; AVO: F(2, 430) = 51.34, p<.001; SOC: 
F(2, 427) = 8.51, p<.001; BOR: F(2, 427) = 66.28, p<.001; PAR: F(2, 427) = 31.64, 
p<.001; ANX: F(2, 427) = 76.21, p<.001; SCHIZ: F(2, 427) = 19.44, p<.001; MAN: F(2, 
427) = 21.92, p<.001; OCPD: F(2, 427) = 16.50, p<.001. It should be noted that the 
Levene’s test of the homogeneity of variance was not satisfied for 3 of the main scales 
(DEP: p=.005, BOR: p=.004, and PAR: p=.031), but was satisfied for the rest of the 
scales at p>.14 or higher. 
A post-hoc analysis (Tukey’s) was done to determine specific differences between 
groups on the Somatization, Avoidant, Sociopathy, Anxiety, Schizotypy, and Mania 
scales as they passed the Levene’s test of homogeneity of variance. Tukey’s post-hoc 
analysis revealed that all three groups did significantly differ at p<.01, to correct for Type 
I error, on each of the 10 main scales except for the following: The chronic pain group’s 
mean score on the Sociopathy scale was higher than the control group but did not 
significantly differ (p=.62). This suggests that the Sociopathy scale may not be able to 
differ between the chronic pain group and the control group or that chronic pain and 
healthy control subjects do not differ when it comes to sociopathy. The chronic pain 
group and the depression group did not significantly differ on 4 of the main scales 
including the Anxiety scale (p=.07), Mania scale (p=.33), OCPD (p=.06), and the 
Schizotypy scale (p=.97). The chronic pain group’s mean score on the Anxiety, Mania, 
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and OCPD scales were lower than the depression group, but not significantly different. 
The depression group’s mean score was lower, but not significantly different, on the 
Schizotypy scales. This means that the CAPI does not differentiate these two patient 
populations on these scales.  
A post-hoc analysis (Games-Howell) was done to determine specific differences 
between groups on the Depression, Borderline, and Paranoia scales as they did not pass 
the Levene’s test of homogeneity of variance and Games-Howell is designed for unequal 
variances and is based on the q-statistic distribution. This shows a significant difference 
on all scales (p<.005) except for one. The depression group’s mean score on the 
Depression scale was higher than the chronic pain group’s mean score, but was not 
significantly different (p=.12). This means that the two groups are not able to be 
differentiated on another of the main scales (Depression), though the depression group 
did score higher, which is what the scale is intended to do. 
The area under the curve (AUC) on the Depression scale for the depression group 
and on the Somatic scale for the chronic pain group are Figure 1 and Figure 2, 
respectively. The AUC measures sensitivity and specificity; how often the scale 
accurately predicts depression and somatization on depressed and chronic pain patients, 
respectively, and how often they don’t have depression and somatization when they do 
not. The area under the curve for the Depression scale for the Depressed group is .72, 
which would be considered fair. The area under the Somatic scale for the Chronic Pain 
group is .83, which would be considered good.  
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Table I – CAPI Reliability for Chronic Pain group 
Scale Number of 
items 
Cronbach Alpha Mean SD 
Somatization (SOM) 
 
Depression (DEP) 
 
Avoidant (AVO) 
 
Borderline (BOR) 
 
Sociopathy (SOC) 
 
Paranoia (PAR) 
 
Anxiety (ANX) 
 
Schizotypy (SCHIZ) 
 
Mania/Bipolar (BI) 
 
OCPD (OCPD) 
15 
 
15 
 
15 
 
15 
 
19 
 
15 
 
15 
 
15 
 
15 
 
10 
.793 
 
.914 
 
.874 
 
.869 
 
.713 
 
.897 
 
.905 
 
.799 
 
.801 
 
.693 
39.40 
 
36.46 
 
37.25 
 
28.02 
 
41.41 
 
29.26 
 
38.18 
 
24.39 
 
29.87 
 
20.93 
7.57 
 
9.96 
 
8.60 
 
8.26 
 
7.30 
 
8.64 
 
9.63 
 
6.74 
 
7.22 
 
4.91 
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Table II – CAPI Reliability for Depressed group 
Scale Number of 
items 
Cronbach Alpha Mean SD 
Somatization (SOM) 
 
Depression (DEP) 
 
Avoidant (AVO) 
 
Borderline (BOR) 
 
Sociopathy (SOC) 
 
Paranoia (PAR) 
 
Anxiety (ANX) 
 
Schizotypy (SCHIZ) 
 
Mania/Bipolar (BI) 
 
OCPD (OCPD) 
15 
 
15 
 
15 
 
15 
 
19 
 
15 
 
15 
 
15 
 
15 
 
10 
.828 
 
.915 
 
.849 
 
.848 
 
.753 
 
.896 
 
.880 
 
.835 
 
.796 
 
.678 
33.23 
 
38.70 
 
41.81 
 
32.12 
 
38.54 
 
32.70 
 
40.68 
 
24.20 
 
31.10 
 
22.31 
8.10 
 
10.10 
 
7.80 
 
8.18 
 
7.70 
 
8.90 
 
8.61 
 
6.98 
 
6.99 
 
4.89 
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Table III – CAPI Reliability for Healthy Control group 
Scale Number of 
items 
Cronbach Alpha Mean SD 
Somatization (SOM) 
 
Depression (DEP) 
 
Avoidant (AVO) 
 
Borderline (BOR) 
 
Sociopathy (SOC) 
 
Paranoia (PAR) 
 
Anxiety (ANX) 
 
Schizotypy (SCHIZ) 
 
Mania/Bipolar (BI) 
 
OCPD (OCPD) 
15 
 
15 
 
15 
 
15 
 
19 
 
15 
 
15 
 
15 
 
15 
 
10 
.819 
 
.920 
 
.890 
 
.872 
 
.733 
 
.888 
 
.923 
 
.838 
 
.841 
 
.724 
24.40 
 
25.20 
 
31.83 
 
22.02 
 
37.07 
 
25.04 
 
28.29 
 
20.23 
 
25.89 
 
19.04 
6.90 
 
8.60 
 
8.40 
 
6.37 
 
7.00 
 
7.38 
 
9.26 
 
5.87 
 
7.14 
 
4.91 
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Table IV – CAPI Reliability across all 3 groups 
Scale Number of 
items 
Cronbach Alpha Mean SD 
Somatization (SOM) 
 
Depression (DEP) 
 
Avoidant (AVO) 
 
Borderline (BOR) 
 
Sociopathy (SOC) 
 
Paranoia (PAR) 
 
Anxiety (ANX) 
 
Schizotypy (SCHIZ) 
 
Mania/Bipolar (BI) 
 
OCPD (OCPD) 
15 
 
15 
 
15 
 
15 
 
19 
 
15 
 
15 
 
15 
 
15 
 
10 
.881 
 
.938 
 
.896 
 
.890 
 
.743 
 
.906 
 
.928 
 
.835 
 
.822 
 
.711 
31.90 
 
33.05 
 
36.69 
 
27.12 
 
38.91 
 
28.80 
 
35.34 
 
22.80 
 
28.80 
 
20.68 
9.80 
 
11.30 
 
9.24 
 
8.67 
 
7.54 
 
8.86 
 
10.67 
 
6.79 
 
7.46 
 
5.08 
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Figure 1. Measure of specificity and sensitivity of the Depression scale for the depressed 
participants. 
 
 
Area Under the Curve 
Test Result Variable(s):   DEP   
Area 
.722 
The test result variable(s): DEP has at least one tie 
between the positive actual state group and the 
negative actual state group. Statistics may be biased. 
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Figure 2. Measure of specificity and sensitivity of the Somatic scale for the chronic pain 
participants. 
 
Area Under the Curve 
Test Result Variable(s):   SOM   
Area 
.828 
The test result variable(s): SOM has at least one tie 
between the positive actual state group and the 
negative actual state group. Statistics may be biased. 
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 Figures 3-6 show the T-score profiles on each of the 10 main scales and the 
Naiveté scale for chronic pain participants (Figure 4), depressed participants (Figure 5), 
healthy controls (Figure 6), and all three overlapping (Figure 3).  
 
Figure 3. Overlapping CAPI profiles with chronic pain participants in blue, depression 
participants in orange, and healthy control participants in gray.  
 
SOM DEP AVO SOC BOR PAR ANX SCIZ BI OCPD N
Series1 57.82 52.97 50.50 49.27 51.04 50.51 52.66 52.34 51.43 50.51 51.21
Series2 51.12 55.09 55.49 52.79 55.76 54.40 55.00 52.06 53.09 53.21 47.94
Series3 42.35 43.05 44.91 48.21 44.12 45.75 43.39 46.22 46.10 46.79 50.74
40.00
42.00
44.00
46.00
48.00
50.00
52.00
54.00
56.00
58.00
60.00
A
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ra
ge
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re
Overlapping Profiles
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Figure 4. Chronic Pain participant profile for the 10 main CAPI scales and the Naiveté 
scale. 
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Figure 5. Depressed participant profile for the 10 main CAPI scales and the Naiveté 
scale. 
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Figure 6. Healthy control participant profile for the 10 main CAPI scales and the Naiveté 
scale. 
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4.2 DSQ Reliability and Validity 
 
 Prior to the removal of questions, the DSQ had excellent reliability (Cronbach α = 
.92). For the 56-question DSQ, the Bartlett’s test of sphericity was significant (χ2 (395) = 
4327.39, p<.001). The Kaiser-Meyer Olkin measure of sampling adequacy was .93, well 
above the commonly recommended value of .60. However, the MSA values on the anti-
image matrix were .65 or above and some partial correlation values were above .8. This 
indicates that some questions needed to be removed due to multicollinearity prior to 
completing a factor analysis.  
A total of 36 questions were removed due to multicollinearity and to shorten the 
questionnaire to make it more feasible for use in the clinical field. After the removal of 
36 questions the DSQ had even better overall reliability (Cronbach α = .95). The resulting 
DSQ was 20 questions in length, the Bartlett’s test of sphericity was still significant (χ2 
(395) = 4633.40, p<.001) and the Kaiser-Meyer Olkin measure of sampling adequacy 
was improved to .96. The MSA values on the anti-image matrix were all above .90, and 
the partial correlation values were .70 or below, further confirming that each item shared 
some common variance with other items. Therefore, factor analysis was deemed suitable 
after the removal of highly multicollinear questions.  
The factor analysis used a principal component extraction method with a varimax 
rotation. There were three possible factors, but after examining the eigenvalues and 
removing all factors below a value of 2 that did not account for at least 6% of the 
variance there was only one factor. The primary factor accounted for 50.05% of the 
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variance in individual’s responses. Upon examining the scree plot, the eigenvalue 
analysis that defined only one factor exists was supported.  
The area under the curve for each of the three possible factors and the full, 56-
question DSQ is shown in Figure 7. The area under the Somatic Scale Final (56-question 
DSQ) curve is 0.80, which would be considered fair. The AUC for the Somatic Scale 20 
Item (20-question DSQ) is 0.85, which improved to good after the removal of 36 
questions. The 20-question DSQ improved on all the factors’ area under the curve and 
improved on the 56-question DSQ, which means the shortened DSQ is the most effective 
at discriminating between chronic pain participants and healthy participants (Figure 8). 
A one-way analysis of variance (ANOVA) was calculated on each of the three 
groups (chronic pain, healthy controls, and depressed participants) to determine if they 
significantly differ on the DSQ. The analysis shows that they do significantly differ on 
the DSQ F(2, 392) = 156.87, p<.001. Post-hoc analysis (LSD and Tukey’s) showed a 
significant difference between all groups (p<.001).  
An analysis between women and men was not performed due to lack of male 
participants. 
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Figure 7. Measure of specificity and sensitivity of the 56-item DSQ and the possible 
factors for all participants. 
 
Area Under the Curve 
Test Result Variable(s) Area 
Somatic_Scale_Final .799 
REGR factor score   1 for analysis 2 .791 
REGR factor score   2 for analysis 2 .601 
REGR factor score   3 for analysis 2 .748 
The test result variable(s): Somatic_Scale_Final has at least 
one tie between the positive actual state group and the 
negative actual state group. Statistics may be biased. 
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Figure 8. Measure of specificity and sensitivity of the 20-item DSQ and the possible 
factors for all participants. 
Area Under the Curve 
Test Result Variable(s) Area 
Somatic_Scale_20_item .850 
REGR factor score   1 for analysis 2 .789 
REGR factor score   2 for analysis 2 .600 
REGR factor score   3 for analysis 2 .749 
The test result variable(s): Somatic_Scale_20_item has at 
least one tie between the positive actual state group and the 
negative actual state group. Statistics may be biased. 
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4.3 Discussion 
 
The current study was an attempt to examine the reliability and validity of the 
CAPI among the chronic pain and depression populations. It was also an attempt to 
examine the reliability, validity, and specificity of the DSQ among chronic pain and 
depressed populations. Both questionnaires were shortened from their original form prior 
to or during analysis for practical use in a clinical setting and for increased reliability and 
validity purposes.   
As noted above, the CAPI was a very reliable and valid questionnaire for all three 
groups of participants (healthy, chronic pain, and depressed). The one-way ANOVAs on 
each of the scales showed that the chronic pain group and depression group did not 
significantly differ on 5 of the main scales. This is not surprising as chronic pain patients 
often suffer from depression and anxiety, (Fishbain, Cutler, Rosomoff, & Rosomoff, 
1997; Poole, White, Blake, Murphy, & Bramwell, 2009; Sullivan, Reesor, Mikail, & 
Fisher, 1992; Worz, 2003) making differentiating between these two groups very 
difficult. It was found that the depressed group scored higher, though not significantly 
higher the Depression, Anxiety, Mania, and OCPD scales, which could mean that these 
scales are close to being able to differentiate the chronic pain population despite the 
comorbidity rates, but are not quite adequate yet. Further work will need to be done on 
these scales to properly differentiate between the two groups on the Depression, Anxiety, 
Mania, OCPD, and Schizotypy scales. 
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 Chronbach’s α showed acceptable (α=.711) to excellent (α=.938) across all three 
groups on each scale. There were only two reliabilities lower than acceptable for each 
group on every scale. These were on the OCPD scale in the depression population 
(α=.68) and the chronic pain population (α=.69), which is considered questionable 
reliability. Overall, the CAPI is a highly reliable questionnaire.  
The area under the curve (AUC), measuring specificity and sensitivity, for the 
depression population on the depression scale was fair. This indicates that the depression 
scale can accurately predict depression when the subject does have depression 
(sensitivity) and accurately identify patients as not having depression when they do not 
(specificity) within the depressed population, even when depression is highly comorbid 
with chronic pain. The AUC for the chronic pain population on the somatic scale was 
good, indicating that the somatic scale is sensitive and specific when identifying the 
chronic pain (including fibromyalgia) population. This shows that the depression and 
somatic scales are both reliable and valid within their respective populations.   
 The DSQ was also a reliable and valid questionnaire, which was specific and 
sensitive to chronic pain patients. Post-hoc analysis (Tukey’s and LSD) revealed that the 
DSQ significantly differentiates between chronic pain, depressed, and healthy control 
populations (p<.001). However, the factor analysis showed that there were not three 
factors, as theorized, just one. This means it is unable to distinguish between emotional, 
cognitive, and physical issues; therefore, it cannot help narrow down a diagnosis for 
practitioners. The shortened, 20-item DSQ improved reliability, sensitivity, and 
specificity from the longer DSQ, which makes it a very quick way for clinicians to assess 
functioning in their chronic pain patients. The results showed that the 20-item DSQ 
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would be best used as a measure of severity in overall functioning than as a 
diagnostically relevant tool as it does not distinguish between emotional health, 
behavioral health, and mental health as theorized.  
 
4.3.1. Limitations of This Study 
 
A significant limitation to this study is the fact that the DSQ was taken by 326 
women and only 66 men and the CAPI was taken by 352 women and only 70 men. 
Researchmatch.org metrics (2017) updates very regularly, but at the time of this 
publication it shows of the over 113,000 volunteers, 70.8% are female, 28.9% are male, 
and .3% are transgender. This makes the generalizability to the population very difficult 
as the sample population was not equally distributed between sexes. Another limitation to 
note is that researchmatch.org metrics (2017), shows that 76.4% of participants are white. 
Though race was not collected in the experiment it could be assumed that the sample 
population of races were not equally distributed, which limits generalizability to the 
population. 
Another possible limitation is the web-based means of collecting data. Hardré, 
Crowson, Xie, and Ly (2007) found that web-based and computer-based administration 
of questionnaires in research collected poorer quality data than paper-based in controlled 
laboratory conditions. The poorer quality data may be attributed to computer anxiety in 
certain populations (Schulenber & Yurtzenka, 1999), which could diminish over time as 
all ages become more familiar and comfortable with computers. However, many studies 
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have shown that web-based questionnaires are just as reliable and generalizable as a 
paper-pencil questionnaire (Davis, 1999; Gosling, Vazire, Srivastava, & John, 2004). The 
CAPI will be primarily a web-based personality questionnaire, but to have the best, most 
reliable data for the validation of the CAPI and the DSQ, it may be best to have in-
person, paper-pencil questionnaire data as well as web-based data.  
 
4.3.2 Future Research 
 
Further studies should be performed on male participants to ensure that the DSQ 
and CAPI can discriminate between male chronic pain, depressed, and healthy 
participants as this study had significantly fewer males compared to females. Though, 
research does show that women suffer from chronic pain conditions, like fibromyalgia, 
and depression at twice the prevalence of men (Munce & Stewart, 2007; Wolfe, Ross, 
Anderson, & Russell, 1995; Yunus, 2001). Future studies should also collect race data to 
ensure the data is generalizable to the population based on race. 
Researchmatch.org is a self-report, volunteer-based website. This means that 
many of the participants could have self-diagnosed themselves with chronic pain or 
depression. This study should be repeated with a confirmed physician-diagnosed sample 
of participants. This additional research would help ensure the profiles developed by T-
scores in each of the 11 scales in this experiment for chronic pain patients, healthy 
controls, and depressed patients are accurate. It would also confirm that the CAPI and 
DSQ are reliable and valid measures with significant results.  
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CHAPTER V 
CONCLUSION 
 
 In summary, the present study provides further evidence that the CAPI is a 
reliable and valid personality inventory that emphasizes modern diagnostic criteria with 
minimal time required for practitioner and patient. The collaborative nature of the 
inventory will improve the usefulness of such a personality inventory and increase the 
usefulness in practice. The DSQ is also a reliable and valid chronic pain questionnaire 
that can be useful in practice as a measure of functionality within the chronic pain 
population, however, cannot identify what underlying issues the patient may be having 
(e.g. mental health, emotional health, behavioral health). Future research should be done 
to further the development of profiles for the CAPI, especially the OCPD scale, among 
different patient populations.  
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APPENDICIES 
APPENDIX  
DSM-5 criteria for Somatic Symptom and Related Disorders 
SOMATIC SYMPTOM AND RELATED DISORDERS 
 
Somatic Symptom Disorder 
Key Criteria: 
One or more somatic symptoms that are distressing or result in significant disruption of 
daily life 
Excessive thoughts, feelings, or behaviors related to the somatic symptoms 
The state of being symptomatic is persistent, more than 6 months, whether somatic 
symptoms are continuous or not 
 
 
Illness Anxiety Disorder 
Key Criteria: 
Preoccupation with having or acquiring a serious illness 
Somatic symptoms are not present or, if present, are only mild in intensity 
There is a high level of anxiety about health 
Health-related behaviors are performed excessively or exhibits maladaptive avoidance 
behaviors 
Illness preoccupation has been present for 6 months or more 
Illness preoccupation cannot be explained by another disorder 
 
 
Conversion Disorder 
Key Criteria: 
One or more symptoms of altered voluntary motor or sensory function 
Clinical findings provide evidence of incompatibility between the symptom and 
recognized neurological or medical conditions 
Symptom is not better explained by another medical/mental disorder 
Symptom causes clinical significant distress 
 
 
Psychological Factors Affecting Other Medical Conditions 
Key Criteria: 
Medical symptom or condition (other than mental disorder) is present 
Psychological or behavioral factors adversely affect the medical condition 
The psychological and behavioral factors are not better explained by another mental 
disorder 
 
 
Factitious Disorder (Imposed on Self) 
Key Criteria: 
Falsification of physical or psychological signs or symptoms 
Individual presents to others as ill, impaired, or injured 
Deceptive behavior is evident even in the absence of obvious external rewards 
Behavior is not better explained by another mental disorder 
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APPENDIX  
 
ICD-10 Criteria for Somatic Symptom and Other Related Disorders 
F45.0 Somatization disorder The main features are multiple, recurrent and 
frequently changing physical symptoms of at 
least two years duration. Most patients have 
a long and complicated history of contact 
with both primary and specialist medical care 
services, during which many negative 
investigations or fruitless exploratory 
operations may have been carried out. 
Symptoms may be referred to any part or 
system of the body. The course of the 
disorder is chronic and fluctuating, and is 
often associated with disruption of social, 
interpersonal, and family behavior. Short-
lived (less than two years) and less striking 
symptom patterns should be classified under 
undifferentiated somatoform disorder 
(F45.1). 
F45.1 Undifferentiated somatoform 
disorder 
When somatoform complaints are multiple, 
varying and persistent, but the complete and 
typical clinical picture of somatization 
disorder is not fulfilled, the diagnosis of 
undifferentiated somatoform disorder should 
be considered. 
F45.2 Hypochondriacal disorder The essential feature is a persistent 
preoccupation with the possibility of having 
one or more serious and progressive physical 
disorders. Patients manifest persistent 
somatic complaints or a persistent 
preoccupation with their physical 
appearance. Normal or commonplace 
sensations and appearances are often 
interpreted by patients as abnormal and 
distressing, and attention is usually focused 
upon only one or two organs or systems of 
the body. Marked depression and anxiety are 
often present, and may justify additional 
diagnoses. 
F45.3 Somatoform autonomic dysfunction Symptoms are presented by the patient as if 
they were due to a physical disorder of a 
system or organ that is largely or completely 
under autonomic innervation and control, i.e. 
the cardiovascular, gastrointestinal, 
respiratory and urogenital systems. The 
.30 Heart and cardiovascular system 
.31 Upper gastrointestinal tract 
.32 Lower gastrointestinal tract 
.33 Respiratory system 
.34 Genitourinary system 
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.38 Other organ or system symptoms are usually of two types, neither of 
which indicates a physical disorder of the 
organ or system concerned. First, there are 
complaints based upon objective signs of 
autonomic arousal, such as palpitations, 
sweating, flushing, tremor, and expression of 
fear and distress about the possibility of a 
physical disorder. Second, there are 
subjective complaints of a nonspecific or 
changing nature such as fleeting aches and 
pains, sensations of burning, heaviness, 
tightness, and feelings of being bloated or 
distended, which are referred by the patient 
to a specific organ or system. 
F45.4 Persistent somatoform pain disorder The predominant complaint is of persistent, 
severe, and distressing pain, which cannot be 
explained fully by a physiological process or a 
physical disorder, and which occurs in 
association with emotional conflict or 
psychosocial problems that are sufficient to 
allow the conclusion that they are the main 
causative influences. The result is usually a 
marked increase in support and attention, 
either personal or medical. Pain presumed to 
be of psychogenic origin occurring during the 
course of depressive disorders or 
schizophrenia should not be included here. 
F45.8 Other somatoform disorders Any other disorders of sensation, function 
and behavior, not due to physical disorders, 
which are not mediated through the 
autonomic nervous system, which are limited 
to specific systems or parts of the body, and 
which are closely associated in time with 
stressful events or problems. 
F45.9 Somatoform disorder, unspecified Psychosomatic disorder NOS 
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APPENDIX  
 
CONSENT FORM 
 
Cleveland State University  
Department of Psychology 
2300 Chester Avenue, Room 158 
Cleveland, OH 44115-2214 
Consent Form 
Study title: Cleveland Adaptive Personality Inventory (CAPI) with Additional Physical 
Symptoms Questions 
Sponsor: N/A 
PI: Amir Poreh, PhD 216-704-1507 
Student Study Coordinator (under observation of PI): Elizabeth Perry 740-605-4937 
After hours phone contact #: 740-605-4937 
 
Please note: 
 You are being asked to take part in a research study. 
 Ask as many questions as needed so you can make your choice. 
 You must be 18 years of age or older to take part. 
 
1. ABOUT THE RESEARCH 
 Why is the study being done? 
 The study is to find out if the CAPI and the additional questions about your physical 
symptoms will be a useful tool to help find mental disorders. Some people with physical 
problems also have a mental disorder. If the CAPI helped find these people, it would help their 
doctor chose the best treatment for them. 
The CAPI has been given to college students, but has not yet been given to people with long-
lasting, long-term pain. We hope to learn more about why certain people develop this kind of pain 
when others do not. You are being asked to join in this study because you have long-lasting, long-
term pain or you do not have any long-lasting, long-term pain and will be a control. 
What is involved if you decide to take part in this research study? 
Taking part in the study includes finishing 330 questions on the CAPI and an 
additional 56 questions about your physical health. Taking all 386 question should take 
about 60-120 minutes. The questionnaire can be taken at any time after consenting 
through the SurveyMonkey website link. 
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2. RISKS 
   What are the risks of taking part in the research study? 
  There are no physical risks involved with this study. You can choose not to 
answer any question if you wish. There is a small risk of loss of privacy. Every effort will 
be made to keep your answers safe. 
 
     3. BENEFITS 
   What are benefits of taking part in the research study? 
There are no direct benefits to you by taking part in this research.  
 
4. COSTS & PAYMENT 
   Are there any costs or payments to you if you take part in this study? 
There are no costs or payments to you for taking part in this study. 
5. PRIVACY  
   What will happen to your information that is collected for this research? 
Your answers to the questions will be kept private. The data will be kept on a secure 
database. Your name will be changed to a number so your data will be safe. You will not be 
identified in any way from this study or in any data files shared with other researchers.  
You may decide not to allow use of your data at any time by getting in touch with the 
Principal Investigator (PI) or student study coordinator, who is supervised by the PI, by using the 
phone numbers or address listed at the top.  
You will be given the questionnaire through SurveyMonkey.com’s secure site.  
6. CONFLICT OF INTEREST 
   Do the researchers or institution have any conflicts of interest relating to this study? 
 There are no conflicts of interest to report.  
7. QUESTIONS 
    Who do you call if you have any questions or problems?  
If you have any questions or problems, please contact Amir Poreh, PhD at 216-704-1597. 
After business hours, call 740-605-4937 and ask for Elizabeth Perry, the student study 
coordinator.  
8. TAKING PART IS OPTIONAL   
     What are your rights? 
 Taking part in this study is completely up to you. You may choose not to take part or may 
leave the study at any time with no penalty. 
9. SIGNATURES 
Please read the following: “I understand that if I have any questions about my rights as a research 
subject, I can contact the Cleveland State University Institutional Review Board at (216) 687-
3630.” 
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After signing this form, please print one copy for your records. 
 
Your electronic signature below on SurveyMonkey.com means that you understand the contents of 
this document. You also are at least 18 years of age.  Finally, you voluntarily consent to participate 
in this research study.   
 
_____________________________ 
Printed name of person obtaining consent 
 
_____________________________  ___________   
Signature of person obtaining consent        Date    
 
 
